The Dow Jones Industrial Average (NYSEARCA:DIA) is down today by 0.93% and stands at 11,843. These stocks are winning despite the sell off.
GE (NYSE:GE) holds its own after Credit Suisse ups estimates with remarks that although the company’s margins are down, energy revenue should return to growth in Q4. The firm raises its overall EPS estimates to $1.36 for 2011, $1.50 for 2012 and $1.71 for 2013. On another note, Sterne Agee thinks the company’s stock could be ready to bounce back given the beneficial results from the company’s recent restructuring.
GE shares recently traded at $16.67, up $0.25, or 1.52%. They have traded in a 52-week range of $14.02 to $21.65. Volume today was 46,531,969 shares versus a 3-month average volume of 69,162,400 shares. The company’s trailing P/E is 12.75, while trailing earnings are $1.31 per share.
Investing Insights: Is Gold’s Bull Market Over?
Pfizer (NYSE:PFE) and Merck (NYSE:MRK): Fitch is setting forth a negative 2012 outlook for pharmaceutical companies, saying the industry will take a hit from patent expirations, weak demand and government spending cuts. Fitch foresees the companies dealing with these problems by ramping up their M&A activity.
PFE shares recently traded at $20.99, up $0.23, or 1.11%. They have traded in a 52-week range of $16.63 to $21.45. Volume today was 38,142,090 shares versus a 3-month average volume of 47,380,900 shares. The company’s trailing P/E is 14.58, while trailing earnings are $1.44 per share.
MRK shares recently traded at $35.75, up $0.76, or 2.17%. They have traded in a 52-week range of $29.47 to $37.65. Volume today was 13,235,694 shares versus a 3-month average volume of 17,352,900 shares. The company’s trailing P/E is 26.13, while trailing earnings are $1.37 per share.